Michael Aiello, DO
Interventional Pain Medicine · Plantation, FLNPI 1710448659
Payments from drug & device makers
What this record shows
This record is dominated by grants: $16,780 of the $23,005 with a category attached, or 72.9%. 14 manufacturers reported payments, led by Medtronic at 47.7% of the total. Reporting peaked in 2023 at $18,264 and has fallen 86.9% since, to $2,386 in 2025.
Across 99 payments — averaging $232.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Boston Scientific$7K
- Abbott$4K
- Globus Medical$352
- Collegium Pharmaceutical, Inc.$218
- Biotronik NRO, Inc.$157
- plus $413 from 8 others
What the payments were for
- Grants$16,78073%
- Travel & lodging$2,26610%
- Food & beverage$3,95817%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $10,981 |
| Boston Scientific | 29 | $7,299 |
| Abbott | 12 | $3,585 |
| Globus Medical | 10 | $352 |
| Collegium Pharmaceutical, Inc. | 13 | $218 |
| Biotronik NRO, Inc. | 2 | $157 |
| Spinal Simplicity, LLC | 1 | $94 |
| Saluda Medical Americas, Inc. | 3 | $93 |
| Baudax Bio Inc. | 1 | $64 |
| SPR Therapeutics, Inc | 4 | $49 |
| Acacia Pharma Inc | 1 | $43 |
| Bioventus LLC | 1 | $25 |
| Curonix LLC | 1 | $24 |
| Valinor Pharma, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$10,000
- WaveWriter Alpha Prime 16$4,199
- VANTA ADAPTIVESTIM$382
- ETERNA$188
- Intracept$148
- Senza$133
- Prospera$121
How this compares
$23,005 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $256 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Plantation
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.